Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer.
Suzuki Y, Iwamoto T, Uno M, Hatono M, Kajiwara Y, Takahashi Y, Kochi M, Shien T, Kikawa Y, Uemura Y, Hagiwara Y, Yamamoto S, Taira N, Doihara H, Toyooka S. Suzuki Y, et al. Among authors: uno m. Breast Cancer. 2023 Sep;30(5):856-868. doi: 10.1007/s12282-023-01480-3. Epub 2023 Jul 8. Breast Cancer. 2023. PMID: 37422608
Current Multidisciplinary Approach to Fertility Preservation for Breast Cancer Patients.
Takahashi Y, Shien T, Sakamoto A, Tsuyumu Y, Yoshioka R, Uno M, Hatono M, Kochi M, Kawada K, Tsukioki T, Iwamoto T, Ikeda H, Taira N, Matsuoka J, Nakatsuka M, Doihara H. Takahashi Y, et al. Among authors: uno m. Acta Med Okayama. 2018 Apr;72(2):137-142. doi: 10.18926/AMO/55854. Acta Med Okayama. 2018. PMID: 29674762 Free article.
Ectopic Breast Cancer Arising within an Axillary Lymph Node.
Toshima K, Shien T, Nishimura MF, Suzuki Y, Nakamoto S, Uno M, Yoshioka R, Tsukioki T, Takahashi Y, Iwamoto T, Iwatani T, Yanai H. Toshima K, et al. Among authors: uno m. Acta Med Okayama. 2024 Feb;78(1):89-93. doi: 10.18926/AMO/66676. Acta Med Okayama. 2024. PMID: 38419320 Free article.
YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development.
Fujihara M, Shien T, Shien K, Suzawa K, Takeda T, Zhu Y, Mamori T, Otani Y, Yoshioka R, Uno M, Suzuki Y, Abe Y, Hatono M, Tsukioki T, Takahashi Y, Kochi M, Iwamoto T, Taira N, Doihara H, Toyooka S. Fujihara M, et al. Among authors: uno m. Int J Mol Sci. 2021 Nov 26;22(23):12809. doi: 10.3390/ijms222312809. Int J Mol Sci. 2021. PMID: 34884609 Free PMC article.